Published in Aliment Pharmacol Ther on November 01, 2003
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother (1999) 9.01
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 5.79
Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet (1999) 5.41
Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother (2000) 5.26
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin. J Bacteriol (1983) 4.42
Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus. Antimicrob Agents Chemother (1985) 3.98
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Aliment Pharmacol Ther (2011) 3.10
HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol (1998) 3.05
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis (2000) 2.98
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis (2000) 2.61
Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother (1991) 2.61
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother (2001) 2.29
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations. Aliment Pharmacol Ther (2012) 2.28
Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother (1985) 2.19
Short rib-dysplasia group (with/without polydactyly): report of a patient suggesting the existence of a continuous spectrum. Am J Med Genet (1995) 2.15
Solubilization and isolation of the membrane-bound DD-carboxypeptidase of Streptococcus faecalis ATCC9790. Properties of the purified enzyme. Eur J Biochem (1978) 2.10
Comparison of the MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria from various clinical specimens. J Clin Microbiol (1999) 2.09
The penicillin-binding proteins in Streptococcus faecalis ATCC 9790. Eur J Biochem (1980) 2.07
Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol (1996) 2.01
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc (2000) 1.97
Identification of the lethal target of benzylpenicillin in Streptococcus faecalis by in vivo penicillin binding studies. Nature (1980) 1.96
Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol (2001) 1.95
Bacteriolytic activity in staphylococci. Infect Immun (1977) 1.90
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy (2010) 1.89
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology (1999) 1.86
Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase. FEMS Microbiol Lett (2001) 1.80
Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet (1985) 1.75
Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci. J Antimicrob Chemother (1985) 1.73
Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther (2000) 1.73
Influence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors. J Clin Oncol (1984) 1.72
[Incidence and age of onset of larynx, bladder and infantile tumours in the Province of Turin in relation to industrial development(author's transl)]. Med Lav (1981) 1.72
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS (2000) 1.67
Carbapenem-resistant Pseudomonas aeruginosa with acquired bla(vim) metallo-beta-lactamase determinants, Italy. Emerg Infect Dis (2000) 1.65
Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut (2009) 1.65
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol (2000) 1.62
Detection of abnormal lesions recorded by capsule endoscopy. A prospective study comparing endoscopist's and nurse's accuracy. Dig Liver Dis (2006) 1.61
Streptococcus faecium ATCC 9790 penicillin-binding proteins and penicillin sensitivity are heavily influenced by growth conditions: proposal for an indirect mechanism of growth inhibition by beta-lactams. J Bacteriol (1983) 1.60
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1998) 1.60
High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther (2003) 1.57
Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J Pediatr Gastroenterol Nutr (1993) 1.55
Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob Agents Chemother (1992) 1.54
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J Hepatol (2000) 1.51
In Streptococcus faecium penicillin-binding protein 5 alone is sufficient for growth at sub-maximal but not at maximal rate. J Gen Microbiol (1986) 1.51
Cell cultures from small amounts of heparinized whole blood enhance HIV-1 isolation rate. AIDS (1990) 1.50
Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerg Infect Dis (1997) 1.49
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol (1997) 1.48
Contribution of artificial neural networks to the classification and treatment of patients with uninvestigated dyspepsia. Dig Liver Dis (2003) 1.46
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
Prevalence of anti-HCV among spouses and offspring of anti-HCV positive subjects: an Italian multicentre study. Ital J Gastroenterol (1995) 1.43
Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone. Ital J Gastroenterol Hepatol (1999) 1.43
Growth charts for cri-du-chat syndrome: an international collaborative study. Am J Med Genet (2000) 1.43
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatol Int (2014) 1.41
Peptidoglycan synthesis in cocci and rods of a pH-dependent, morphologically conditional mutant of Klebsiella pneumoniae. J Bacteriol (1979) 1.40
Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39
Aminopyrine breath test. Dig Dis Sci (1994) 1.39
Nonradioactive DNA probe for detection of gene for methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.39
Microscopic colitis progressed to collagenous colitis: a morphometric study. Ital J Gastroenterol (1996) 1.39
Identification of a gene (arpU) controlling muramidase-2 export in Enterococcus hirae. J Bacteriol (1995) 1.38
Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins. J Bacteriol (1987) 1.38
Identification of a genetic element (psr) which negatively controls expression of Enterococcus hirae penicillin-binding protein 5. J Bacteriol (1993) 1.36
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34
Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphomas in childhood: a case-control study. Tumori (1990) 1.33
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob Agents Chemother (1995) 1.29
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Bacteriostatic and bactericidal activities of beta-lactams against Streptococcus (Enterococcus) faecium are associated with saturation of different penicillin-binding proteins. Antimicrob Agents Chemother (1987) 1.26
Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet (2001) 1.26
Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology (2000) 1.26
Detection of bacterial phosphatase activity by means of an original and simple test. J Clin Pathol (1979) 1.26
Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis (1998) 1.23
The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology (1994) 1.23
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strains. J Clin Microbiol (1999) 1.23
Changes of gallbladder and gastric dynamics in patients with acute hepatitis A. Eur J Clin Invest (2001) 1.23
Gastric abnormalities in cholera: epidemiological and clinical considerations. Bull World Health Organ (1974) 1.22
Control of cell septation by lateral wall extension in a pH-conditional morphology mutant of Klebsiella pneumoniae. J Bacteriol (1980) 1.22
Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1996) 1.21
Characterization of a conditional mutant with altered envelope showing pH-dependent morphology and temperature-dependent division. J Gen Microbiol (1974) 1.19
Different staphylococcal species contain various numbers of penicillin-binding proteins ranging from four (Staphylococcus aureus) to only one (Staphylococcus hyicus). J Bacteriol (1985) 1.19
Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol (2006) 1.18